This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...

Roman Trawicki Biography and Net Worth

EVP of Zoetis

Roman Trawicki serves as Executive Vice President, President - Global Manufacturing and Supply of the Company. Mr. Trawicki has served as our Executive Vice President and President, Global Manufacturing and Supply since May 2015. He joined Zoetis in January 2015 as President, Global Manufacturing and Supply. From 2009 to 2014, he was GE Healthcare’s General Manager of Global Supply Chain for Medical Diagnostics, where he focused on diagnostics, injectable contrast media and nuclear medicines.

What is Roman Trawicki's net worth?: The estimated net worth of Roman Trawicki is at least $1.28 million as of April 7th, 2020. Mr. Trawicki owns 8,340 shares of Zoetis stock worth more than $1,279,022 as of April 25th. This net worth evaluation does not reflect any other investments that Mr. Trawicki may own. Learn More about Roman Trawicki's net worth.
How do I contact Roman Trawicki?: The corporate mailing address for Mr. Trawicki and other Zoetis executives is 10 Sylvan Way, Parsippany NJ, 07054. Zoetis can also be reached via phone at (973) 822-7000 and via email at [email protected]. Learn More on Roman Trawicki's contact information.
Has Roman Trawicki been buying or selling shares of Zoetis?: Roman Trawicki has not been actively trading shares of Zoetis during the last ninety days. Most recently, Roman Trawicki sold 6,000 shares of the business's stock in a transaction on Wednesday, March 16th. The shares were sold at an average price of $188.15, for a transaction totalling $1,128,900.00. Learn More on Roman Trawicki's trading history.
Who are Zoetis' active insiders?: Zoetis' insider roster includes Juan Alaix (Director), Heidi Chen (EVP), Glenn David (EVP), Andrew Fenton (EVP), Wetteny Joseph (Exec. VP & CFO ), Robert Kelly (EVP), Catherine Knupp (EVP), Roxanne Lagano (EVP), Clinton Lewis, Jr. (EVP), Gregory Norden (Director), Kristin Peck (CEO), Robert Polzer (EVP), Willie Reed (Director), Linda Rhodes (Director), Robert Scully (Director), and Roman Trawicki (EVP). Learn More on Zoetis' active insiders.
Are insiders buying or selling shares of Zoetis?: In the last twelve months, insiders at the sold shares 13 times. They sold a total of 46,408 shares worth more than $8,362,102.41. The most recent insider tranaction occured on April, 18th when EVP Roxanne Lagano sold 923 shares worth more than $139,529.91. Insiders at Zoetis own 0.1% of the company. Learn More about insider trades at Zoetis.
Information on this page was last updated on 4/18/2024.

Roman Trawicki Insider Trading History at Zoetis

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/16/2022	Sell	6,000	$188.15	$1,128,900.00
10/1/2021	Sell	4,497	$194.14	$873,047.58
4/7/2020	Sell	5,499	$130.00	$714,870.00	8,340
1/15/2020	Sell	2,199	$137.41	$302,164.59
6/6/2019	Sell	4,700	$109.00	$512,300.00	2,199
3/1/2019	Sell	17,873	$95.10	$1,699,722.30
8/7/2018	Sell	8,266	$92.53	$764,852.98
3/9/2018	Sell	8,568	$83.10	$712,000.80	11,457
2/23/2018	Sell	23,885	$82.00	$1,958,570.00

Roman Trawicki Buying and Selling Activity at Zoetis

Zoetis Company Overview

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Today's Range

Now: $153.36

$150.04

$153.59

50 Day Range

MA: $172.39

$145.54

$199.94

2 Week Range

Now: $153.36

$144.80

$201.92

Volume

4,555,033 shs

Average Volume

3,093,786 shs

Market Capitalization

$70.14 billion

P/E Ratio

30.25

Dividend Yield

1.19%

Beta

0.85

Jim Cramer’s “The Biggest Drug Ever”

From Behind the Markets | Ad